ARCOSA INC (ACA) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:ACA - US0396531008 - Common Stock
116.21 USD
+3.96 (+3.53%)
ACA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 54 industry peers in the Construction & Engineering industry. Both the profitability and the financial health of ACA get a neutral evaluation. Nothing too spectacular is happening here. ACA is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
- ACA had positive earnings in the past year.
- In the past year ACA had a positive cash flow from operations.
- Each year in the past 5 years ACA has been profitable.
- In the past 5 years ACA always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 2.94%, ACA is in line with its industry, outperforming 46.30% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 5.75%, ACA is in line with its industry, outperforming 40.74% of the companies in the same industry.
- ACA's Return On Invested Capital of 4.99% is in line compared to the rest of the industry. ACA outperforms 46.30% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for ACA is significantly below the industry average of 15.99%.
- The 3 year average ROIC (3.99%) for ACA is below the current ROIC(4.99%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.94% | ||
| ROE | 5.75% | ||
| ROIC | 4.99% |
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
1.3 Margins
- With a decent Profit Margin value of 5.25%, ACA is doing good in the industry, outperforming 62.96% of the companies in the same industry.
- ACA's Profit Margin has declined in the last couple of years.
- ACA has a Operating Margin of 10.27%. This is in the better half of the industry: ACA outperforms 72.22% of its industry peers.
- In the last couple of years the Operating Margin of ACA has declined.
- ACA has a better Gross Margin (21.61%) than 64.81% of its industry peers.
- ACA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.27% | ||
| PM (TTM) | 5.25% | ||
| GM | 21.61% |
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
2. Health
2.1 Basic Checks
- ACA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, ACA has more shares outstanding
- The number of shares outstanding for ACA has been increased compared to 5 years ago.
- ACA has a worse debt/assets ratio than last year.
2.2 Solvency
- ACA has an Altman-Z score of 2.48. This is not the best score and indicates that ACA is in the grey zone with still only limited risk for bankruptcy at the moment.
- ACA's Altman-Z score of 2.48 is in line compared to the rest of the industry. ACA outperforms 42.59% of its industry peers.
- The Debt to FCF ratio of ACA is 5.03, which is a neutral value as it means it would take ACA, 5.03 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of ACA (5.03) is better than 62.96% of its industry peers.
- A Debt/Equity ratio of 0.61 indicates that ACA is somewhat dependend on debt financing.
- ACA has a Debt to Equity ratio (0.61) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 5.03 | ||
| Altman-Z | 2.48 |
ROIC/WACC0.5
WACC9.9%
2.3 Liquidity
- ACA has a Current Ratio of 2.02. This indicates that ACA is financially healthy and has no problem in meeting its short term obligations.
- ACA has a better Current ratio (2.02) than 88.89% of its industry peers.
- ACA has a Quick Ratio of 1.30. This is a normal value and indicates that ACA is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.30, ACA is in line with its industry, outperforming 55.56% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.02 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 17.03% over the past year.
- The Earnings Per Share has been growing slightly by 5.16% on average over the past years.
- The Revenue has grown by 13.96% in the past year. This is quite good.
- The Revenue has been growing by 8.15% on average over the past years. This is quite good.
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
Revenue 1Y (TTM)13.96%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%
3.2 Future
- The Earnings Per Share is expected to grow by 22.53% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 7.41% on average over the next years.
EPS Next Y41.21%
EPS Next 2Y27.26%
EPS Next 3Y22.53%
EPS Next 5YN/A
Revenue Next Year10.81%
Revenue Next 2Y8.38%
Revenue Next 3Y7.41%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 30.74, which means the current valuation is very expensive for ACA.
- ACA's Price/Earnings ratio is a bit cheaper when compared to the industry. ACA is cheaper than 66.67% of the companies in the same industry.
- ACA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.33.
- The Price/Forward Earnings ratio is 23.84, which indicates a rather expensive current valuation of ACA.
- Based on the Price/Forward Earnings ratio, ACA is valued a bit cheaper than the industry average as 72.22% of the companies are valued more expensively.
- The average S&P500 Price/Forward Earnings ratio is at 24.12. ACA is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.74 | ||
| Fwd PE | 23.84 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ACA is valued cheaply inside the industry as 81.48% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, ACA is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.12 | ||
| EV/EBITDA | 13.29 |
4.3 Compensation for Growth
- ACA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as ACA's earnings are expected to grow with 22.53% in the coming years.
PEG (NY)0.75
PEG (5Y)5.95
EPS Next 2Y27.26%
EPS Next 3Y22.53%
5. Dividend
5.1 Amount
- With a yearly dividend of 0.18%, ACA is not a good candidate for dividend investing.
- ACA's Dividend Yield is a higher than the industry average which is at 0.40.
- With a Dividend Yield of 0.18, ACA pays less dividend than the S&P500 average, which is at 1.91.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.18% |
5.2 History
- The dividend of ACA decreases each year by -0.48%.
- ACA has been paying a dividend for over 5 years, so it has already some track record.
- As ACA did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)-0.48%
Div Incr Years0
Div Non Decr Years5
5.3 Sustainability
- ACA pays out 6.66% of its income as dividend. This is a sustainable payout ratio.
DP6.66%
EPS Next 2Y27.26%
EPS Next 3Y22.53%
NYSE:ACA (1/15/2026, 3:30:44 PM)
116.21
+3.96 (+3.53%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-25 2026-02-25/amc
Inst Owners94.81%
Inst Owner Change0.01%
Ins Owners1.8%
Ins Owner Change-1.18%
Market Cap5.70B
Revenue(TTM)2.83B
Net Income(TTM)148.60M
Analysts86
Price Target122.2 (5.15%)
Short Float %2.27%
Short Ratio4.79
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.18% |
Yearly Dividend0.2
Dividend Growth(5Y)-0.48%
DP6.66%
Div Incr Years0
Div Non Decr Years5
Ex-Date01-15 2026-01-15 (0.05)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.63%
Min EPS beat(2)15.61%
Max EPS beat(2)17.65%
EPS beat(4)3
Avg EPS beat(4)38.79%
Min EPS beat(4)-40.32%
Max EPS beat(4)162.24%
EPS beat(8)7
Avg EPS beat(8)30.62%
EPS beat(12)11
Avg EPS beat(12)32.12%
EPS beat(16)15
Avg EPS beat(16)40.53%
Revenue beat(2)1
Avg Revenue beat(2)-1.27%
Min Revenue beat(2)-3.72%
Max Revenue beat(2)1.18%
Revenue beat(4)2
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-4.44%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.83%
Revenue beat(12)7
Avg Revenue beat(12)0.53%
Revenue beat(16)11
Avg Revenue beat(16)1.99%
PT rev (1m)-0.03%
PT rev (3m)3.28%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.23%
EPS NY rev (1m)0%
EPS NY rev (3m)5.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.55%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.74 | ||
| Fwd PE | 23.84 | ||
| P/S | 2.01 | ||
| P/FCF | 18.12 | ||
| P/OCF | 12.15 | ||
| P/B | 2.21 | ||
| P/tB | 6.21 | ||
| EV/EBITDA | 13.29 |
EPS(TTM)3.78
EY3.25%
EPS(NY)4.87
Fwd EY4.19%
FCF(TTM)6.41
FCFY5.52%
OCF(TTM)9.57
OCFY8.23%
SpS57.76
BVpS52.7
TBVpS18.72
PEG (NY)0.75
PEG (5Y)5.95
Graham Number66.95
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.94% | ||
| ROE | 5.75% | ||
| ROCE | 6.5% | ||
| ROIC | 4.99% | ||
| ROICexc | 5.24% | ||
| ROICexgc | 8.62% | ||
| OM | 10.27% | ||
| PM (TTM) | 5.25% | ||
| GM | 21.61% | ||
| FCFM | 11.11% |
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
ROICexc(3y)4.17%
ROICexc(5y)4.21%
ROICexgc(3y)7.17%
ROICexgc(5y)7.33%
ROCE(3y)5.21%
ROCE(5y)5.27%
ROICexgc growth 3Y4.01%
ROICexgc growth 5Y-10.09%
ROICexc growth 3Y4.98%
ROICexc growth 5Y-11.63%
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
F-Score5
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 5.03 | ||
| Debt/EBITDA | 3.04 | ||
| Cap/Depr | 68.36% | ||
| Cap/Sales | 5.46% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 90.74% | ||
| Profit Quality | 211.71% | ||
| Current Ratio | 2.02 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 2.48 |
F-Score5
WACC9.9%
ROIC/WACC0.5
Cap/Depr(3y)104.81%
Cap/Depr(5y)89.02%
Cap/Sales(3y)7.45%
Cap/Sales(5y)6.15%
Profit Quality(3y)128.08%
Profit Quality(5y)133.99%
High Growth Momentum
Growth
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
EPS Next Y41.21%
EPS Next 2Y27.26%
EPS Next 3Y22.53%
EPS Next 5YN/A
Revenue 1Y (TTM)13.96%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%
Revenue Next Year10.81%
Revenue Next 2Y8.38%
Revenue Next 3Y7.41%
Revenue Next 5YN/A
EBIT growth 1Y48.65%
EBIT growth 3Y20.99%
EBIT growth 5Y5.01%
EBIT Next Year135.94%
EBIT Next 3Y39.06%
EBIT Next 5YN/A
FCF growth 1Y5015.62%
FCF growth 3Y56.55%
FCF growth 5Y2.7%
OCF growth 1Y146.35%
OCF growth 3Y44.47%
OCF growth 5Y6.95%
ARCOSA INC / ACA FAQ
Can you provide the ChartMill fundamental rating for ARCOSA INC?
ChartMill assigns a fundamental rating of 5 / 10 to ACA.
Can you provide the valuation status for ARCOSA INC?
ChartMill assigns a valuation rating of 6 / 10 to ARCOSA INC (ACA). This can be considered as Fairly Valued.
How profitable is ARCOSA INC (ACA) stock?
ARCOSA INC (ACA) has a profitability rating of 5 / 10.
What is the valuation of ARCOSA INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ARCOSA INC (ACA) is 30.74 and the Price/Book (PB) ratio is 2.21.
How financially healthy is ARCOSA INC?
The financial health rating of ARCOSA INC (ACA) is 5 / 10.